Efficacy of human papillomavirus vaccine in subjects with bone marrow failure syndrome
Latest Information Update: 27 Apr 2015
At a glance
- Drugs Human papillomavirus vaccine recombinant bivalent Japan Vaccine/MedImmune (Primary) ; Human papillomavirus vaccine recombinant quadrivalent Merck (Primary)
- Indications Cervical cancer; Human papillomavirus infections
- Focus Pharmacodynamics
Most Recent Events
- 27 Apr 2015 New trial record